Alice Lorusso Publishes Study on Optimized Pathogen Reduction for Double-Dose Platelets
Alice Lorusso, Senior Medical Scientist at Irish Blood Transfusion Service, posted on LinkedIn:
”Thrilled to share that my paper “Optimized pathogen reduction of double-dose platelets pooled from seven buffy coats using the TACSI system” has been published in Vox Sanguinis.
This study explores how double-dose platelet components can be safely pathogen-reduced while maintaining excellent in-vitro quality and compliance with EDQM specifications.
Grateful to my co-authors and colleagues for the teamwork and dedication that made this possible ”
Read the full article here.
Title: Optimized pathogen reduction of double-dose platelets pooled from seven buffy coats using the TACSI® system
Authors: Alice Lorusso, Liam Morgan, Aileen Farrelly, Mark Lambert, Barry Doyle, Paul Hendrick, Einas Elsheikh, Andrew Godfrey, Tor Hervig, Allison Waters
Stay updated with Hemostasis Today.
-
Jul 2, 2026, 23:11Michael Makris: Join The Cancer Associated Thrombosis Workshop at ISTH 2026
-
Jul 2, 2026, 21:54Rob Maloney: Rare Disease Requires Relational Care
-
Jul 2, 2026, 21:53Quintijn Bonnez: How ADAMTS13 Conformation May Predict Early Relapse and Guide Pre-Emptive Therapy
-
Jul 2, 2026, 21:52Emina Curic: Improving the Understanding of Factor V Leiden in Everyday Clinical Practice
-
Jul 2, 2026, 21:49Lee Peter Bee: The Plastic in Your Blood Is Sabotaging Your Stem Cells
-
Jul 2, 2026, 21:49Atef Ahmed: The Lethal Triad and Damage Control Philosophy
-
Jul 2, 2026, 20:48João L. Carapinha: How Does HYMPAVZI Simplify Hemophilia Management for Patients?
-
Jul 2, 2026, 20:15Celebrationg The 30 Years Anniversary as The Voice of Stroke in Australia – Stroke Foundation
-
Jul 2, 2026, 19:40Minoo Ahmadinejad: Improving the Recognition of Women and Girls With Hemophilia